Australia markets close in 54 minutes

Aptose Biosciences Inc. (APTO)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.2100+0.0100 (+0.83%)
At close: 04:00PM EDT
1.1900 -0.02 (-1.65%)
After hours: 07:28PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 18.94M
Enterprise value 10.70M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)3.35
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.21

Trading information

Stock price history

Beta (5Y monthly) 1.42
52-week change 3132.69%
S&P500 52-week change 323.57%
52-week high 36.6000
52-week low 30.3600
50-day moving average 31.5032
200-day moving average 32.5594

Share statistics

Avg vol (3-month) 378.45k
Avg vol (10-day) 349.11k
Shares outstanding 515.72M
Implied shares outstanding 616.18M
Float 812.52M
% held by insiders 119.07%
% held by institutions 17.41%
Shares short (15 Apr 2024) 454.93k
Short ratio (15 Apr 2024) 40.65
Short % of float (15 Apr 2024) 40.35%
Short % of shares outstanding (15 Apr 2024) 40.35%
Shares short (prior month 15 Mar 2024) 450.18k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:12
Last split date 306 Oct 2014

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-102.23%
Return on equity (ttm)-293.95%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -52.27M
Net income avi to common (ttm)-51.21M
Diluted EPS (ttm)-7.5800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)9.25M
Total cash per share (mrq)0.59
Total debt (mrq)1.01M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.78
Book value per share (mrq)-0.37

Cash flow statement

Operating cash flow (ttm)-44.59M
Levered free cash flow (ttm)-25.82M